Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.

Montes D, Langenfeld HE, Hanson AC, Crowson CS, Patnaik MM, Go RS, Kalantari K, Kusne Y, Lasho T, Mangaonkar AA, Olteanu H, Reichard KK, Sullivan MM, Viswanatha DS, Warrington KJ, Koster MJ

Open source

DOI
10.1002/acr2.90153
Published
2026 Oct
Container
ACR open rheumatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr2.90153,
  title = {Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.},
  author = {Montes D and Langenfeld HE and Hanson AC and Crowson CS and Patnaik MM and Go RS and Kalantari K and Kusne Y and Lasho T and Mangaonkar AA and Olteanu H and Reichard KK and Sullivan MM and Viswanatha DS and Warrington KJ and Koster MJ},
  year = {2026},
  journal = {ACR open rheumatology},
  doi = {10.1002/acr2.90153},
  url = {https://doi.org/10.1002/acr2.90153}
}

RIS

TY  - JOUR
TI  - Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.
AU  - Montes D
AU  - Langenfeld HE
AU  - Hanson AC
AU  - Crowson CS
AU  - Patnaik MM
AU  - Go RS
AU  - Kalantari K
AU  - Kusne Y
AU  - Lasho T
AU  - Mangaonkar AA
AU  - Olteanu H
AU  - Reichard KK
AU  - Sullivan MM
AU  - Viswanatha DS
AU  - Warrington KJ
AU  - Koster MJ
PY  - 2026
JO  - ACR open rheumatology
DO  - 10.1002/acr2.90153
UR  - https://doi.org/10.1002/acr2.90153
ER  - 

APA

D, M., HE, L., AC, H., CS, C., MM, P., RS, G., K, K., Y, K., T, L., AA, M., H, O., KK, R., MM, S., DS, V., KJ, W., & MJ, K. (2026). Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome.. ACR open rheumatology. https://doi.org/10.1002/acr2.90153

Source records